CLAUDIA MOLLES: Open Payments
NPI 1932557675 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,379 in 46 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $563 · 2025 $1,379
Food & beverage: $1,379
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $364 |
| Boston Scientific Corporation | 4 | $286 |
| AstraZeneca Pharmaceuticals LP | 10 | $193 |
| Optinose US, Inc. | 2 | $150 |
| Lilly USA, LLC | 5 | $94 |
| Exact Sciences Corporation | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| PFIZER INC. | 2 | $36 |
| Astellas Pharma US Inc | 1 | $27 |
Products named: WATCHMAN FLX, Xhance, OTEZLA, REPATHA, JARDIANCE, FARXIGA, AIRSUPRA, Cologuard Collection Kit.
Industry payments across AZ — which companies pay providers there.
